AP-1 Mediates Cellular Adaptation and Memory Formation During Therapy Resistance
Jingxin Li(Beijing Tongren Hospital), Arjun Raj(University of Pennsylvania)
Cited by 14
Related Papers
An integrative drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|Signal Transduction and Targeted Therapy|2021|204
Safety and immunogenicity of heterologous boost immunisation with an orally administered aerosolised Ad5-nCoV after two-dose priming with an inactivated SARS-CoV-2 vaccine in Chinese adults: a randomised, open-label, single-centre trial
|The Lancet Respiratory Medicine|2022|172
A data-driven drug repositioning framework discovered a potential therapeutic agent targeting COVID-19
|bioRxiv (Cold Spring Harbor Laboratory)|2020|168